MedPal AI (LSE:MPAL) PS Ratio: 7.75 (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is MedPal AI PS Ratio?

MedPal AI LSE:MPAL PS Ratio is 7.75 as of Aug. 04, 2026. The stock has 1 warning sign investors should review. Among 657 Healthcare Providers & Services companies, MedPal AI ranks worse than 87.37% on this metric.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, MedPal AI's share price is £0.031. MedPal AI's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 was £0.00. Hence, MedPal AI's PS Ratio for today is 7.75.

The historical rank and industry rank for MedPal AI's PS Ratio or its related term are showing as below:

LSE:MPAL' s PS Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 8.63
Current: 7.41

During the past 4 years, MedPal AI's highest PS Ratio was 8.63. The lowest was 0.00. And the median was 0.00.

LSE:MPAL's PS Ratio is ranked worse than
87.37% of 657 companies
in the Healthcare Providers & Services industry
Industry Median: 1.49 vs LSE:MPAL: 7.41

MedPal AI's Revenue per Sharefor the six months ended in Feb. 2026 was £0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 was £0.00.

Back to Basics: PS Ratio


MedPal AI  (LSE:MPAL) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


MedPal AI PS Ratio Related Terms


MedPal AI PS Ratio Historical Data

* Premium members only.

The historical data trend for MedPal AI's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedPal AI PS Ratio Chart

MedPal AI Annual Data
Trend Aug22 Aug23 Aug24 Aug25
PS Ratio
0.00 0.00 0.00 0.00

MedPal AI Semi-Annual Data
Aug22 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
PS Ratio Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

LSE:MPAL vs VEEV, BTSG, HQY: PS Ratio Comparison

For the Health Information Services subindustry, MedPal AI's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedPal AI PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedPal AI's PS Ratio distribution charts can be found below:

* The bar in red indicates where MedPal AI's PS Ratio falls into.



MedPal AI PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

MedPal AI's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.031/0.004
=7.75

MedPal AI's Share Price of today is £0.031.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MedPal AI's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 was £0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 7.75 mean?
MedPal AI (LSE:MPAL) has a PS Ratio of 7.75 as of Aug. 04, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on MedPal AI and its competitors. According to the industry distribution chart, MedPal AI ranks #574 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 87.4%.
Is MedPal AI's PS Ratio too high?
MedPal AI's current PS Ratio is 7.75. The Healthcare Providers & Services industry median PS Ratio is 1.49. MedPal AI's value of 7.75 is 420.1% above this industry median. Based on the distribution chart, MedPal AI ranks #574 out of 657 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does MedPal AI's PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedPal AI ranks #574 out of 657 companies for PS Ratio. This places MedPal AI in the lower half of its industry. The industry median PS Ratio is 1.49. MedPal AI's value of 7.75 is 420.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.49, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedPal AI's current PS Ratio of 7.75 is 420.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on MedPal AI and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedPal AI's current PS Ratio is 7.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current PS Ratio of 7.75. The current PS Ratio is 7.75 and 420.1% above the Healthcare Providers & Services industry median of 1.49. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current PS Ratio is 7.75 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedPal AI Business Description

Other Exchanges Z1N:Germany
Address 71 Queen Victoria Street, Floor 8, London, GBR, EC4V 4AY
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.